Genentech Headquarters is located at 1 DNA Way Mailstop 258A, South San Francisco, CA 94080-4990, United States. Established in 1976, Genentech is a leading biotechnology company that uses human genetic information to develop, manufacture and commercialize medicines to treat patients with serious and life-threatening medical conditions. With headquarters in the heart of South San Francisco, the company is committed to discovering, developing, manufacturing and commercializing innovative medicines to address unmet medical needs and transform the lives of patients.
Genentech Headquarters Address, Phone and Contact Details
1 DNA Way Mailstop 258A
South San Francisco
Genentech Headquarters is located in South San Francisco, CA. The address is 1 DNA Way, Mailstop 258A, South San Francisco, CA 94080-4990, United States. This is the headquarters of Genentech, a biotechnology company that specializes in developing and manufacturing medicines for serious and life-threatening diseases.
Genentech Corporate Headquarters Executive Team
The Genentech Headquarters Executive Team is comprised of experienced and innovative industry leaders who are dedicated to driving the company’s success. The team is led by Chief Executive Officer, Dr. Albert Bourla, and includes the following members:
Chief Financial Officer: Paul B. Clancy
Chief Medical Officer: Dr. Sandra Horning
Chief Human Resources Officer: K.C. Jones
Chief Technology Officer: Shingo Yamada
Chief Operating Officer: Ian Clark
Chief Legal Officer: Mark Berman
Chief Business Officer: Rachel Howshall
Chief Communications Officer: Lisa Tuomi
Chief Strategy Officer: Mike Burgess
Chief Scientific Officer: Tom Daniels
Genentech Headquarters Location & Directions
Founded in 1976, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company has a strong focus on innovation through research and development, and it has been recognized as a pioneer in the biotechnology industry. Genentech has a portfolio of approved treatments for various diseases, including cancer, immunology, and neurology. The company is committed to providing new treatments and improving existing therapies to improve the lives of patients.